ReviewDrugs & aging1997
Drug selection for optimal treatment of hypertension in the elderly.
Review in Drugs & aging, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 8 citations in OpenAlex.
- Fixed dose combination therapy in the treatment of hypertension.Journal of human hypertension · 2002Review
- Losartan: a review of its use, with special focus on elderly patients.Drugs & aging · 2000Review
- Drug dosage in the elderly. Is it rational?Drugs & aging · 1998Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Progressive aging of the world's population means that choosing the most effective drugs for the elderly is becoming increasingly important. The treatment of hypertension in the elderly is complicated because of the need to consider altered pharmacokinetics, comorbidity and multiple drug therapy in these patients. Antihypertensive treatment in the elderly has important and documented beneficial effects. However, no single drug class is suitable as the first-choice therapy for all elderly patients. The most appropriate choice of an antihypertensive drug often depends on comparative adverse effect profiles and the presence of comorbid disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.